CAPTRUST Financial Advisors
CTSO icon

CAPTRUST Financial Advisors’s Cytosorbents Corp CTSO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,922
Closed -$4K – 2501
2022
Q2 		$4K Buy
1,922
+1,476
+331% +$3.39K ﹤0.01% 4173
2022
Q1 		$1K Sell
446
-36
-7% -$129 ﹤0.01% 4673
2021
Q4 		$2K Buy
482
+311
+182% +$1.75K ﹤0.01% 4395
2021
Q3 		$1K Hold
171
– – ﹤0.01% 4412
2021
Q2 		$1K Hold
171
– – ﹤0.01% 4319
2021
Q1 		$1K Buy
+171
New +$1.63K ﹤0.01% 4176

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CAPTRUST Financial Advisors's CTSO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 1,922 shares — an estimated $4K sold.

CAPTRUST Financial Advisors first reported a position in CTSO in Q1 2021 and held it in 6 quarters. The position peaked at $4K in Q2 2022. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,922 Cytosorbents Corp shares in Q3 2022, an estimated $4K.
  • CAPTRUST Financial Advisors first reported a position in Cytosorbents Corp in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Cytosorbents Corp position peaked at $4K in Q2 2022.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.